Health And Pharma

Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

ONCOLife

FDA Grants Breakthrough Designation to First Urine-Based Multi-Cancer Early Detection Test

ONCOLife

Daraxonrasib Doubles Overall Survival in Previously Treated Metastatic Pancreatic Cancer

ONCOLife

MD Anderson Study Identifies DPY30 as Therapeutic Target in Pancreatic Cancer

ONCOLife

New Strategy Blocks NMD, Unmasks Hidden Tumor Antigens, and Boosts Immunotherapy

ONCOLife

Blocking DHODH Helps Triple Combination Overcome Resistance in Lung Cancer

ONCOLife

New B7-H3 Radio-Theranostic Promises to Broaden Targeted Radiation Across Solid Tumors

ONCOLife

Immunotherapy Boosts Chemo Cutting Recurrence Risk by 50% in Colon Cancer

ONCOLife

Nonviral Gene Delivery Platform Offers Promise for Cancer Treatment and Cell Therapy

ONCOLife

New IHC Biomarker Test Predicts Which Gastric Cancer Patients Benefit from Immunotherapy

ONCOLife Issues

Featured Articles

AACR 2026 Data Show Multi-Biomarker MCED Approach Improves Early Cancer Detection

17 April 2026

At AACR 2026, Abbott presented data on Cancerguard, a multi-biomarker blood-based MCED test that combines methylation and protein signals to improve cancer detection. In 3,163 samples, 47.1% of positive calls were methylation-only, 7.4% protein-only, and 45.5%...

Zenocutuzumab Gains NCCN Support as FDA Review Advances in Cholangiocarcinoma

15 April 2026

Illumina Launch 100 K Genome Effort to Advance Cancer and Rare Disease Research

15 April 2026

AI Nodule Detection Helps Sarasota Memorial Reach 75% Early Lung Cancer Diagnosis

15 April 2026

FDA Grants Priority Review to Ifinatamab Deruxtecan in Pretreated ES-SC Lung Cancer

13 April 2026

Phase 2 Data Position Trastuzumab Pamirtecan as a Promising Option in Endometrial Cancer

13 April 2026

Mocertatug Rezetecan Shows Strong Responses in Ovarian and Endometrial Cancers

12 April 2026

Trending Articles

Neladalkib Reaches FDA Review for TKI-Pretreated ALK+ Non-Small Cell Lung Cancer

FDA & EMA | 9 April 2026

FDA Grants Breakthrough Status to WU-CART-007 for T-Cell Leukemias and Lymphomas

FDA & EMA | 1 April 2026

AI Predicts Chemotherapy Benefit in Breast Cancer Using Routine Pathology Slides

Clinical Trials | 30 March 2026

FDA Approves Agilent’s PD-L1 Test to Guide KEYTRUDA Use in Esophageal and GEJ Carcinoma

FDA & EMA | 28 March 2026

Light-Activated Copper Nanoparticles Trigger Cuproptosis in Drug-Resistant Cancer Cells

ONCOLife | 27 March 2026

New Protein Modification Linked to IDH-Mutant Cancers Opens Therapeutic Possibilities

ONCOLife | 26 March 2026

BioNTech Showcases Promising Bispecific and ADC Data in Lung Cancer at ELCC 2026

ONCOLife | 25 March 2026

Sunvozertinib Outperforms Chemo in First-Line EGFR Exon 20 Insertion NSC Lung Cancer

ONCOLife | 22 March 2026

Magnetic Nanoparticle-Guided Hyperthermia Opens a New Path for Advanced Solid Tumors

ONCOLife | 23 March 2026

TG Therapeutics Secures $500M to Advance BRIUMVI in Relapsing Multiple Sclerosis

Biotech | 20 March 2026

Targeted Bladder Cancer Therapy Erda-iDRS Achieves 89% Response Rate and PDC

ONCOLife | 15 March 2026

Atirmociclib Reduces Progression Risk by 40% in CDK4/6 Metastatic Breast Cancer

ONCOLife | 17 March 2026

TALAPRO-3 Trial Supports Early Use of Talazoparib in HRR+ mCS Prostate Cancer

ONCOLife | 20 March 2026

FDA Approves Nivolumab-AVD as First Immunotherapy Combination for Hodgkin Lymphoma

FDA & EMA | 20 March 2026

Abenacianine Enters Phase 3 to Enhance Real-Time Tumor Detection in Lung Surgery

CellCarta Secures Global Exclusivity for Aspyre Lung to Advance Lung Cancer Testing

Cancer

18 March 2026

Reengineering CAR-T Cells to Last Longer in the Fight Against Cancer and HIV

ONCOLife

15 March 2026

Vitamin B2’s Hidden Role in Cancer Survival May Open a New Therapeutic Target

ONCOLife

14 March 2026

Romiplostim Prevents Chemotherapy Side Effects and Preserves Treatment Intensity

ONCOLife

14 March 2026

PSMA PET/CT May Transform Prostate Cancer Diagnosis and Reduce Biopsies by 50%

Breast Cancer Patients Choosing Alternative Medicine Face Four Times Higher Mortality

ONCOLife

9 March 2026

Designing Digital Healthcare Systems for the Future of Patient-Centered Care

Digital Health

4 March 2026

Gut Bacteria Decide Whether Nutrients Feed Tumors or Fuel Immunity

ONCOLife

13 February 2026

Amivantamab Plus Chemotherapy Shows Promising Responses in Colorectal Cancer

Clinical Trials

11 January 2026

Novartis Expands US Radioligand Manufacturing With $23 Billion Investment in Florida

Rewiring RNA: Antisense RNA Therapy Exposes a New Weakness in Pancreatic Cancer

ONCOLife

8 January 2026

TRBC2-Specific ADC Shows Robust Efficacy in T-Cell Lymphomas and Leukemias

Clinical Trials

24 December 2025

Engineered Oncolytic Virus Reprograms Immunity and Extends Survival in Brain Cancer

ONCOLife

20 December 2025

FDA Approves First Subcutaneous Amivantamab Plus Lazertinib for EGFR+ Lung Cancer

FDA & EMA

18 December 2025